Literature DB >> 8994464

Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint.

E Kubota1, H Imamura, T Kubota, T Shibata, K Murakami.   

Abstract

PURPOSE: This study investigated the early signs of synovitis and cartilage degradation by means of synovial fluid analysis in temporomandibular joints (TMJs) with internal derangement (closed lock) or osteoarthritis (OA). PATIENTS AND METHODS: Synovial fluid was obtained from 25 TMJs in 22 patients diagnosed with closed lock and from 15 asymptomatic TMJs of 12 normal controls. IL-1 beta concentrations were measured using enzyme-linked immunosorbent assay (ELISA), and proteinase activity was detected by means of gelatin enzymography.
RESULTS: Nine of the 25 TMJs with closed lock (CL group) exhibited osteolytic changes on the surface of the condyle. TMJs in the normal control group did not show any bony changes. Mean IL-1 beta concentration in the synovial fluid (SF) protein in the CL group was 330.1 +/- 347.7 pg per 100 micrograms protein, which was significantly higher than in the normal control (76.7 +/- 95.3 pg/100 micrograms SF-protein). Synovial fluid from the TMJs with osteolytic changes contained higher levels of IL-1 beta (531.8 +/- 379.6 pg/100 micrograms SF-protein) than those without bony changes (216.7 +/- 280.1 pg/100 micrograms SF-protein). Matrix metalloproteinase (MMP) activity with a molecular weight of 50 kd (stromelysin or MMP3) was detected in a highly augmented form in two synovial fluid samples of seven closed lock patients.
CONCLUSION: The results suggest that IL-1 beta levels in synovial fluid of the TMJ have a positive correlation with OA change. The MMP3 activity detected was greatly increased in patients with cartilage degradation. These findings suggest that both changes may be important markers of early bone deterioration in TMJs that are undetectable by radiograph imaging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8994464     DOI: 10.1016/s0278-2391(97)90438-9

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  25 in total

1.  scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy.

Authors:  L R Goodrich; J C Grieger; J N Phillips; N Khan; S J Gray; C W McIlwraith; R J Samulski
Journal:  Gene Ther       Date:  2015-04-23       Impact factor: 5.250

2.  Minimally Invasive Approach for Diagnosing TMJ Osteoarthritis.

Authors:  B Shoukri; J C Prieto; A Ruellas; M Yatabe; J Sugai; M Styner; H Zhu; C Huang; B Paniagua; S Aronovich; L Ashman; E Benavides; P de Dumast; N T Ribera; C Mirabel; L Michoud; Z Allohaibi; M Ioshida; L Bittencourt; L Fattori; L R Gomes; L Cevidanes
Journal:  J Dent Res       Date:  2019-07-24       Impact factor: 6.116

3.  Differences in signal intensities of temporomandibular joint (TMJ) effusion on fluid-attenuated inversion recovery (FLAIR) images.

Authors:  Mika Otonari-Yamamoto; Kenichi Imoto
Journal:  Oral Radiol       Date:  2018-01-20       Impact factor: 1.852

4.  Sustained intra-articular delivery of IL-1RA from a thermally-responsive elastin-like polypeptide as a therapy for post-traumatic arthritis.

Authors:  K A Kimmerling; B D Furman; D S Mangiapani; M A Moverman; S M Sinclair; J L Huebner; A Chilkoti; V B Kraus; L A Setton; F Guilak; S A Olson
Journal:  Eur Cell Mater       Date:  2015-01-31       Impact factor: 3.942

5.  Association and expression study of MMP3, TGFβ1 and COL10A1 as candidate genes for leg weakness-related traits in pigs.

Authors:  Watchara Laenoi; Noppawan Rangkasenee; Muhammad Jasim Uddin; Mehmet Ulas Cinar; Chirawath Phatsara; Dawit Tesfaye; Armin M Scholz; Ernst Tholen; Christian Looft; Manfred Mielenz; Helga Sauerwein; Klaus Wimmers; Karl Schellander
Journal:  Mol Biol Rep       Date:  2011-07-08       Impact factor: 2.316

6.  Blood-derived anti-inflammatory protein solution blocks the effect of IL-1β on human macrophages in vitro.

Authors:  Krista M O'Shaughnessey; Alyssa Panitch; Jennifer E Woodell-May
Journal:  Inflamm Res       Date:  2011-06-18       Impact factor: 4.575

7.  Caesalpinia sappan extract inhibits IL1β-mediated overexpression of matrix metalloproteinases in human chondrocytes.

Authors:  Stefan Toegel; Shengqian Q Wu; Miguel Otero; Mary B Goldring; Pimporn Leelapornpisid; Catharina Chiari; Alexander Kolb; Frank M Unger; Reinhard Windhager; Helmut Viernstein
Journal:  Genes Nutr       Date:  2011-08-18       Impact factor: 5.523

8.  The potential of multiple synovial-fluid protein-concentration analyses in the assessment of knee osteoarthritis.

Authors:  Jeffrey B Driban; Easwaran Balasubramanian; Mamta Amin; Michael R Sitler; Marvin C Ziskin; Mary F Barbe
Journal:  J Sport Rehabil       Date:  2010-11       Impact factor: 1.931

Review 9.  TMJ disorders: future innovations in diagnostics and therapeutics.

Authors:  Sunil Wadhwa; Sunil Kapila
Journal:  J Dent Educ       Date:  2008-08       Impact factor: 2.264

10.  IL-1beta suppresses the formation of osteoclasts by increasing OPG production via an autocrine mechanism involving celecoxib-related prostaglandins in chondrocytes.

Authors:  Yusuke Watanabe; Aki Namba; Yukiko Aida; Kazuhiro Honda; Hideki Tanaka; Naoto Suzuki; Hideo Matsumura; Masao Maeno
Journal:  Mediators Inflamm       Date:  2010-02-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.